产品功能

应用市场介绍

MOUNJY: THE ONLY COMPLETE GLP-1 TRACKER
Built for tirzepatide and semaglutide users. Log weekly injections, track weight loss, document progress with photos, and get evidence-based health tips—all in one clean app.
SHOT TRACKING
Log every injection with dose, site, and time. Set smart reminders so you never miss a shot. View your full injection history and titration schedule.
WEIGHT & BMI MONITORING
Track weight and BMI with beautiful charts. Set goals, monitor weekly averages, and watch your progress over time.
PROGRESS PHOTOS
Add before-and-after photos, compare side by side, and see your transformation. Secured in a local private gallery.
MEDICATION INVENTORY
Track pens and doses remaining. Get low-stock alerts and know exactly when to refill.
HEALTH TIPS
Evidence-based tips for managing GLP-1 side effects, nutrition, and lifestyle.
DATA EXPORT
Export to PDF or CSV and share detailed reports with your healthcare provider.
WIDGETS
Home screen and lock screen widgets for quick access to your next shot and current weight.
PRIVACY FIRST
Face ID / Touch ID lock. All data stored locally on your device. No ads. No selling your data. Optional Apple Health integration.
---
MOUNJY+ PREMIUM
- Unlimited shot history
- Unlimited progress photos
- Advanced analytics & charts
- Share Cards: shareable progress cards
- Full health tips library
Monthly or yearly. Cancel anytime.
---
FOR YOUR DOCTOR
Export PDF reports covering injections, weight trends, side effects, and nutrition. Make the most of every appointment.
---
WHAT USERS SAY
"Finally, an app that gets GLP-1 users."
"The photo comparison feature is incredible for motivation."
"Simple, clean, and exactly what I needed."
---
Terms of Use: https://mounjy.pages.dev/terms-of-use/ 
Privacy Policy: https://mounjy.pages.dev/privacy-policy/
DISCLAIMER
Mounjy is for tracking and informational purposes only. Not a medical device. Always follow your healthcare provider's instructions.

收起

用户评价

立即分享产品体验

你的真实体验,为其他用户提供宝贵参考

宝石
评论可得 100 宝石
宝石随心兑换应用高级会员,每周更新 前往查看 >>
活动动态 0 人参加
查看更多评论